IGC Pharma (IGC) Total Debt Growth (3y) (2014 - 2026)
IGC Pharma (IGC) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
15.63% |
| Date | Value |
|---|
| Mar 31, 2026 |
15.63% |
| Dec 31, 2025 |
51.57% |
| Sep 30, 2025 |
-2.40% |
| Jun 30, 2025 |
-3.06% |
| Mar 31, 2025 |
-3.04% |
| Dec 31, 2024 |
-3.26% |
| Sep 30, 2024 |
-3.24% |
| Jun 30, 2024 |
-3.21% |
| Mar 31, 2024 |
-38.18% |
| Dec 31, 2023 |
-38.03% |
| Sep 30, 2023 |
-37.89% |
| Jun 30, 2023 |
-39.43% |
| Mar 31, 2023 |
41.28% |
| Dec 31, 2022 |
41.28% |
| Sep 30, 2022 |
41.61% |
| Jun 30, 2022 |
42.93% |
| Mar 31, 2022 |
43.26% |
| Dec 31, 2021 |
32.24% |
| Sep 30, 2021 |
-12.84% |
| Jun 30, 2021 |
-12.82% |
